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Correction for “Paired quantitative and qualitative assessment of
the replication-competent HIV-1 reservoir and comparison with
integrated proviral DNA,” by Julio C. C. Lorenzi, Yehuda Z.
Cohen, Lillian B. Cohn, Edward F. Kreider, John P. Barton,
Gerald H. Learn, Thiago Oliveira, Christy L. Lavine, Joshua A.
Horwitz, Allison Settler, Mila Jankovic, Michael S. Seaman, Arup K.
Chakraborty, Beatrice H. Hahn, Marina Caskey, and Michel C.
Nussenzweig, which appeared in issue 49, December 6, 2016,
of Proc Natl Acad Sci USA (113:E7908–E7916; first published
November 21, 2016; 10.1073/pnas.1617789113).
The authors note that Fig. 3 appeared incorrectly. The cor-
rected figure and its legend appear below.
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Fig. 3. Env sequences from archived proviral DNA. (A) Maximum likelihood phylogenetic trees of full-length env sequences derived by SGA from primary
CD4+ T cells from four individuals. Viruses from time point 1 are green, and viruses from time point 2 are red. Asterisks indicate nodes with significant
bootstrap values (bootstrap support ≥ 70%). (B) Pie charts depict the distribution of archived env sequences from the two time points. The number in the
inner circle indicates the total number of env sequences analyzed. White represents unique sequences isolated only once across both time points, and colored
areas represent identical sequences that appear more than once. The size of the pie slice is proportional to the number of sequences in the clone. Clones
found at both time points are the same color and denoted by asterisks. Percentages of identical sequences are displayed at the bottom right of each pie chart.
(C) Representation of overlapping sequences between the two time points. The size of the hemisphere is proportional to the number of sequences. Light blue
hemispheres represent overlapping sequences and gray hemispheres represent the total number of sequences. The percentage of overlap is indicated at the
bottom of each hemisphere.
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HIV-1–infected individuals harbor a latent reservoir of infected CD4+
T cells that is not eradicated by antiretroviral therapy (ART). This
reservoir presents the greatest barrier to an HIV-1 cure and has
remained difficult to characterize, in part, because the vast majority
of integrated sequences are defective and incapable of reactivation.
To characterize the replication-competent reservoir, we have com-
bined two techniques, quantitative viral outgrowth and qualitative
sequence analysis of clonal outgrowth viruses. Leukapheresis sam-
ples from four fully ART-suppressed, chronically infected individuals
were assayed at two time points separated by a 4- to 6-mo interval.
Overall, 54% of the viruses emerging from the latent reservoir
showed gp160 env sequences that were identical to at least one
other virus. Moreover, 43% of the env sequences from viruses
emerging from the reservoir were part of identical groups at the
two time points. Groups of identical expanded sequences made up
54% of proviral DNA, and, as might be expected, the sequences of
replication-competent viruses in the active reservoir showed limited
overlap with integrated proviral DNA, most of which is known to
represent defective viruses. Finally, there was an inverse correlation
between proviral DNA clone size and the probability of reactivation,
suggesting that replication-competent viruses are less likely to be
found among highly expanded provirus-containing cell clones.
HIV | reservoir | replication-competent | culture | method
Areservoir of latently infected cells persists in HIV-1–infectedindividuals treated with antiretroviral therapy (ART) (1).
This reservoir endures for the lifetime of the individual and pre-
sents the greatest barrier to an HIV-1 cure (2, 3). Although there
is a growing understanding of the cellular and molecular nature of
this compartment, many questions remain about the composition
of the latent reservoir and the ability of current techniques to
characterize it accurately (4, 5).
One of the challenges in studying the reservoir is that the majority
(>90%) of integrated proviruses in CD4+ T-cell DNA are defective
and cannot produce infectious virions (6–9). Comparatively few
cells harbor the replication-competent proviruses that constitute the
clinically relevant reservoir, and there are currently no markers to
distinguish these cells from those cells bearing defective proviruses.
An additional problem is that it is difficult to measure the size of the
replication-competent reservoir accurately. The best available assay
measures the size of the reservoir by limiting dilution cultures under
conditions that favor latent virus outgrowth [quantitative viral
outgrowth assay (QVOA)] (10, 11). However, this assay is typi-
cally performed on peripheral blood and can significantly un-
derestimate the size of the replication-competent reservoir even
within this compartment (7, 9).
Finally, the genetic characteristics of the reservoir have been
studied primarily by sequencing integrated proviral DNA or cell-as-
sociated RNAs, many of which are defective and thus not repre-
sentative of the replication-competent reservoir (12–16). Phylogenetic
analyses of the replication-competent reservoir are usually limited
because bulk outgrowth cultures produce species with little diversity,
even when analyzed by ultra-deep sequencing (17–20).
Here, we report on a modified QVOA that includes a qualitative
measure of the reservoir [qualitative and quantitative viral out-
growth assay (Q2VOA)]. We use the assay to describe the genetic
and biological diversity of the replication-competent reservoir and
examine the relationship between replicating and archived provi-
ruses in CD4+ T cells from the same ART-suppressed individuals
at two time points separated by 4–6 mo.
Results
To investigate the genetic and phenotypic complexity of the rep-
lication-competent reservoir, we modified the QVOA protocol to
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increase the number of unique outgrowth cultures and sequenced
the emerging viruses. Unlike QVOA, where multiple dilutions are
assayed, Q2VOA is performed using a single predetermined di-
lution that produces less than 30% positive wells to maximize the
total number of individual viruses that can be sequenced. Based
on Poisson distribution, this technique produces cultures that are
likely to contain single replication-competent proviruses (Fig. 1).
CD4+ T lymphocytes were isolated from each of four chroni-
cally infected individuals who had been virologically suppressed by
combination ART for 4–22 y at two time points 4–6 mo apart
(Table S1). We tested 0.40–1.44 × 108 CD4+ T lymphocytes from
each ART-treated individual at each time point. On average,
13.5% of cultures were positive for p24. The number of cells
yielding replication-competent viruses varied across individuals
from 0.19 to 1.07 infectious units per million, which is similar to
values obtained by others (3, 6) (Table 1).
To characterize the cultured viruses molecularly, we produced
cDNA from culture supernatants and sequenced the env gene
using primers that resulted in a clonal prediction score of 94 of
100 (silicianolab.johnshopkins.edu/cps) (21). Thus, there was a
high probability that identical env sequences represented identical
full-length genomes. We obtained a total of 234 env sequences from
Q2VOA, of which 13.7% were excluded from further analysis due to
the presence of short reads (3.8%) or the presence of reads pro-
ducing an inconclusive consensus (9.8%). The phylogenetic analysis
of the remaining 202 env sequences showed that the four individuals
were infected with epidemiologically unrelated clade B viruses (Fig.
S1). Phylogenetic analysis of individual sequences revealed the exis-
tence of a diverse viral population composed of multiple (bootstrap-
supported) clusters for each of the four individuals (Fig. 2A).
To compare the diversity of viruses obtained from a “bulk” culture
with the diversity of viruses derived by Q2VOA, we performed single
genome analysis (SGA) on bulk culture supernatants established at
the same time from the same four individuals. In contrast to Q2VOA,
bulk culture supernatants were mainly monotypic and showed much
reduced overall diversity (Fig. 2A). Thus, when multiple infected cells
are reactivated in a single culture, the strain or strains with the fastest
growth kinetics, or the greatest fitness in culture, dominate.
Individual replication-competent viruses obtained from differ-
ent Q2VOA cultures frequently encoded identical env sequences.
When Q2VOA-derived viruses obtained at the two time points
were compared for each subject, typically less than half (40–52%)
of their env sequences were unique (Table 2). The majority of
sequences were identical to at least one other independently de-
rived replication-competent virus obtained from the same subject.
For example, of a total of 49 env sequences isolated from the two
time points from B106, only 21 were unique. The majority (22)
were identical to at least one other sequence that appeared at one
of the two time points. We will refer to these repeated sequences
irrespective of whether they appear at one or both time points as
“clones” because they must originate from at least two different
CD4+ T cells. This finding does not necessarily imply that the
viruses are integrated in the same location in the genome because
it is possible that identical viruses can infect different CD4+ T
cells. The size of these clones ranged from two to 10 members,
with a mean of 3.69 when all four individuals and both time points
were considered (Fig. 2 B and C and Table 2). Fifty-four percent
of all replication-competent viruses emerging in Q2VOA cultures
were derived from expanded clones (Fig. 2 B and C and Table 2).
To determine whether the viral sequences obtained from the
replication-competent reservoir remained stable over time, we
compared the sequences from the two time points for each indi-
vidual. Many branches in the phylogenetic trees contained se-
quences derived from both time points (Fig. 2 A–C and Table 2).
The relationship between the sequences from both time points was
formally assessed by determining their Genealogical Sorting Index
(GSI), which quantitates the degree of phylogenetic association
between sequences (23). GSI values, which range between 0 (com-
plete interspersion) and 1 (complete monophyly), showed that for
each of the four individuals, the sequences obtained by Q2VOA
from both time points could not be segregated as distinct groups
(Table 3). This finding demonstrates that the viral population
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Fig. 1. Quantitative and qualitative analysis of the replication-competent reservoir. Diagrammatic representation of the assay. CD4+ T cells are cultured at a
limiting dilution under conditions whereby a single virus emerges from the latent reservoir in each positive well (red). The number of infectious units per million
(IUPM) is determined directly from the number of p24-positive wells. Virus-containing supernatants from positive cultures are harvested for env sequencing and
neutralization assays.
Table 1. Q2VOA overall results and IUPM
Months between
time points
Total CD4+
cells tested Wells tested
Positive
wells (%) IUPM
Total CD4+
cells tested Wells tested
Positive
wells (%) IUPM
Study ID Time point 1 Time point 2
B106 4 39.6 × 106 132 31 (23.5) 0.89 75.6 × 106 252 28 (11.1) 0.39
B115 4 57.6 × 106 192 40 (20.8) 0.57 140 × 106 468 50 (10.7) 0.38
B155 6 75.6 × 106 252 69 (27.4) 1.07 72 × 106 240 24 (16.7) 0.35
B199 4 43.2 × 106 144 24 (16.7) 0.61 144 × 106 480 26 (5.4) 0.19
ID, identification; IUPM, infectious units per million cells.
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emerging from the latent reservoir in four individuals was stable
over the 4- to 6-mo time interval analyzed.
To examine the relationship between proviruses integrated into
CD4+ T-cell DNA and the replication-competent viruses obtained
by Q2VOA, we performed SGA on DNA isolated from primary
CD4+ T lymphocytes from the same individuals at both time
points. We obtained a total of 498 env sequences, of which 16.3%
were excluded from further analysis due to the presence of
hypermutated regions (2.4%), short reads (5.6%), or reads
producing an inconclusive consensus (8.2%). The remaining
417 full-length env sequences, or 85–113 per individual, fell
within the same four patient-specific clades as the Q2VOA-
derived env sequences, indicating absence of sample mix-up or
contamination (Fig. S1).
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Fig. 2. Env sequences from outgrowth cultures. (A) Maximum likelihood phylogenetic trees of full-length env sequences of viruses from Q2VOA outgrowth
cultures from four individuals. Viruses from time point 1 are green, viruses from time point 2 are red, and bulk culture SGA is gray. Asterisks indicate nodes
with significant bootstrap values (bootstrap support ≥ 70%). Numbers next to sequences correspond to viruses assayed for neutralization in Fig. 6. (B) Pie
charts depict the distribution of culture-derived env sequences from the two time points. The number in the inner circle indicates the total number of env
sequences analyzed. White represents sequences isolated only once across both time points, and colored areas represent identical sequences that appear
more than once. The size of the pie slice is proportional to the number of sequences in the clone. Clones found at both time points are the same color and
denoted by asterisks. Percentages of identical sequences are displayed at the bottom right of each pie chart. (C) Representation of overlapping sequences
between the two time points. The size of the hemisphere is proportional to the number of sequences. Light blue hemispheres represent overlapping se-
quences and gray hemispheres represent the total number of sequences. The percentage of overlap is indicated at the bottom of each hemisphere.
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As previously reported for archived proviral DNA amplified from
primary CD4+ T cells, we found unique sequences, as well as large
groups of identical sequences, marking expanded cell clones (14, 15,
24, 25). For example, in B106, 67 of 113 env sequences obtained
from the two time points were unique and the remaining 46 were
members of clones. In addition, 36 of the 46 identical sequences
overlapped between the two time points (Fig. 3 A and B and Table
4). Thus, like the Q2VOA-derived sequences, the archived proviral
population was stable over the time interval analyzed.
Archived proviral DNA sequences were then compared with
replication-competent Q2VOA-derived sequences. Because both
the proviral DNA and the replication-competent viral sequences
for any given individual were overlapping at the two time points,
we combined each of the two sets of sequences (Fig. 4). As might be
expected, given that the sample size is limited, we found relatively
limited overlap between the archived proviral sequences and
Q2VOA culture-derived sequences in phylogenetic trees, with
multiple large clusters composed of sequences isolated from
only a single source (Fig. 4A). The 417 archived proviral se-
quences contained 50 expanded clones, 12 of which were also
found in the replication-competent outgrowth cultures. The relative
frequency of expanded clones from these two sources differed:
Some greatly expanded clones identified in primary CD4+ T-cell
DNA represented only a small fraction of clones identified in the
outgrowth cultures, and rare archived clones were disproportionally
abundant among the reactivated latent replication-competent viru-
ses (Fig. 4B). This finding is best illustrated in subject B155, where
the largest archived proviral clone, which comprised 28 of 99 total
sequences, was found only once among 52 replication-competent
viruses (Fig. 4 B and C). In contrast, in B199, one archived proviral
sequence, which appeared only once in a total of 120 sequences
derived from primary CD4+ T-cell DNA, was found in 11 of 50
Q2VOA culture-derived sequences emerging from the latent
reservoir. B115 provided the clearest example of the discrepancy
between proviral DNA and cultured viruses, with no instances of
matching sequences between 85 proviral sequences and 50 outgrowth
viruses (Fig. 4 B and C). Although this discrepancy is most likely due
to the prevalence of defective archived proviral sequences (6–9),
differences in proviral accessibility to polymerase may also contribute.
To determine the extent to which sequences from replication-
competent viruses and archived proviruses were compartmentalized,
we calculated their GSI. This analysis demonstrated that ar-
chived proviral and Q2VOA culture-derived sequences were
significantly segregated for every single individual analyzed
(Table 5). Thus, proviral sequences derived from primary CD4+
T-cell DNA do not provide an accurate representation of viruses
comprising the replication-competent reservoir.
To understand the relationship between the two groups of se-
quences better, we analyzed them by a mathematical model that
describes every sequence by two variables (SI Methods). The first
(p) is the frequency of a sequence in the proviral compartment,
and the second (r) is its probability of reactivation in the active
viral culture. These parameters were extracted from the experi-
mental data using Bayesian inference methods. The data show
that clone size is negatively correlated with the activation proba-
bility (r = −0.94, p = 3.4 × 10−34) (Fig. 5). These results indicate
that the larger the clone of archived proviral sequences, the lower
is its probability of representing a replication-competent virus in
the Q2VOA outgrowth culture.
Finally, to characterize the viruses obtained by Q2VOA further,
we tested virus-containing supernatants selected to be represen-
tative of the diversity in the phylogenetic trees for sensitivity to a
panel of broadly neutralizing antibodies (bNAbs) that are cur-
rently in clinical development. As might be expected, there was
significant variation in the sensitivity profile of each individual’s
replication-competent reservoir. In each case, there was at least
one example of coexisting sensitive and resistant viruses for any
one tested bNAb (Fig. 6A). For example, in B155, all but one of
the 10 viruses tested were resistant to 10-1074, a bNAb that targets
the base of the V3 loop and surrounding glycans (26). As might be
expected, the 10-1074–susceptible virus segregated from the oth-
ers in the phylogenetic tree (Fig. 6A and Fig. S2). When results
from all individuals were combined, a large range in sensitivities
was observed against the panel of bNAbs (Fig. 6B). In contrast,
supernatants obtained from the bulk cultures showed bNAb
sensitivity that appeared to be representative of a single viral
cluster in any individual (Fig. 6A). Thus, Q2VOA differs from
bulk cultures in that it enables measurement of the genetic and
phenotypic diversity of the replication-competent reservoir. Fi-
nally, the observation that bNAb neutralization-sensitive and
-resistant clones coexist in the reservoir provides an explanation
for the observation that combination therapy will likely be re-
quired to maintain suppression (27, 28).
Discussion
A long-lived reservoir of HIV-1–infected cells that remain silent in
infected individuals receiving ART is the primary impediment to
HIV-1 cure (22, 29, 30). The reservoir is established early in in-
fection (31) and has an estimated t1/2 of 44 mo (2, 3). Several
mechanisms have been proposed to account for the persistence of
this reservoir, including low-level viral replication, the long t1/2 of
latently infected cells, and the proliferative expansion of these
latently infected cells (5, 32, 33).
Arguments against persistent low-level viral replication include
the observation that further intensification of ART has no mea-
surable effect (34, 35). In addition, there is little evidence for viral
evolution even after prolonged periods of ART (36). In contrast,
Table 2. Distribution of observed sequences in Q2VOA
Nonclonal Clonal
Study ID T1 T2 Total (%) T1 T2 Total (%)
Overlapping sequences between
T1 and T2 (%)
B106 13 8 21/49 (42.9) 12 16 28/49 (57.1) 23/49 (46.9)
B115 9 15 24/50 (48.0) 10 16 26/50 (52.0) 23/50 (46.0)
B155 13 8 21/53 (39.6) 19 13 32/53 (60.4) 21/53 (39.6)
B199 10 16 26/50 (52.0) 13 11 24/50 (48.0) 20/50 (40.0)
Table 3. GSI and probability values for HIV env trees under the
null hypothesis that Q2VOA-derived sequences from both visits
are a single mixed group
Q2VOA
Visit 1 Visit 2
Study ID GSI P value GSI P value
B106 0.067 0.45 0.02 0.92
B115 0.066 0.14 0 1
B155 0.059 0.26 0.012 0.82
B199 0.053 0.3 0 1
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the idea that the reservoir is maintained, at least in part, by the
proliferation of latently infected cells is supported by the obser-
vation of increasing proportions of identical proviral sequences in
circulating CD4+ T cells (15).
Archived proviral integration site analysis provided further sup-
port for clonal expansion of infected T cells (8, 24, 25). In all cases
examined, a large proportion of the archived integrated proviruses
were found to belong to expanded clones of CD4+ T cells that
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Fig. 3. Env sequences from archived proviral DNA. (A) Maximum likelihood phylogenetic trees of full-length env sequences derived by SGA from primary CD4+ T
cells from four individuals. Viruses from time point 1 are green, and viruses from time point 2 are red. Asterisks indicate nodes with significant bootstrap values
(bootstrap support ≥ 70%). (B) Pie charts depict the distribution of archived env sequences from the two time points. The number in the inner circle indicates the
total number of env sequences analyzed. White represents unique sequences isolated only once across both time points, and colored areas represent identical
sequences that appear more than once. The size of the pie slice is proportional to the number of sequences in the clone. Clones found at both time points are the
same color and denoted by asterisks. Percentages of identical sequences are displayed at the bottom right of each pie chart. (C) Representation of overlapping
sequences between the two time points. The size of the hemisphere is proportional to the number of sequences. Light blue hemispheres represent overlapping
sequences and gray hemispheres represent the total number of sequences. The percentage of overlap is indicated at the bottom of each hemisphere.
Table 4. Distribution of observed sequences in proviral DNA
Nonclonal Clonal Overlapping
Study ID T1 T2 Total (%) T1 T2 Total (%)
Sequences between
T1 and T2 (%)
B106 30 37 67/113 (59.3) 13 33 46/113 (40.7) 36/113 (31.9)
B115 6 43 49/85 (57.6) 6 30 36/85 (42.4) 10/85 (11.8)
B155 6 23 29/99 (29.3) 28 42 70/99 (70.7) 58/99 (58.6)
B199 39 9 48/120 (40.0) 50 22 72/120 (60.0) 70/120 (58.3)
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share a unique integration site. However, as expected from the ob-
servation that the vast majority of integrated proviruses are defective
(7, 9), many of the proviruses found in clonally expanded T cells are
also defective (8). The only exception was found in a singular indi-
vidual with metastatic squamous cell carcinoma, which showed a
large expanded clone of replication-competent virus (37). However,
the integration site of the provirus in this individual was ambiguous
and could not be mapped with certainty. Thus, the precise contri-
bution of expanded cell clones bearing replication-competent pro-
viruses to maintaining the latent reservoir is not defined well.
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Fig. 4. Comparison of env sequences from archived proviruses and replication-competent viruses. Sequences from the two time points were pooled for each
patient. (A) Maximum likelihood phylogenetic trees of env sequences. Limiting dilution outgrowth viruses are red, bulk culture viruses are gray, and viral
sequences amplified from primary CD4+ T cells are blue. Asterisks indicate nodes with significant bootstrap values (bootstrap support ≥ 70%). (B) Pie charts
depicting the distribution of archived proviruses and culture-derived sequences. The numbers in the inner circles indicate the total number of env sequences
analyzed. White represents sequences isolated only once, and colored areas represent identical sequences. The size of the pie slice is proportional to the
number of sequences in the clone. Clones found in proviral DNA and outgrowth cultures are the same color and denoted by asterisks. Percentages of identical
groups of sequences are displayed at the bottom right of each pie chart. (C) Representation of overlapping sequences between the two sources. The size of
the hemisphere is proportional to the number of sequences. Light blue hemispheres represent overlapping sequences and gray hemispheres represent the
total number of sequences. The percentage of overlap is indicated at the bottom of each hemisphere.
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To examine the diversity of the latent but replication-competent
reservoir, we developed a modification of current quantitative
viral outgrowth protocols to include a qualitative measure of the
reservoir of replication-competent proviruses. Q2VOA maximizes
the yield of limiting dilution cultures to obtain viruses originating
from a single cell. Consistent with the absence of viral evolution in
individuals on suppressive ART, Q2VOA revealed that the latent
replication-competent viral population is similar between time
points 4–6 mo apart (12, 13, 38). This interval is relatively short in
the life of an infected individual, and it will be interesting to
evaluate the reservoir by Q2VOA over longer time intervals.
Fifty-four percent of the viruses emerging in Q2VOA belonged
to expanded cell clones bearing the same env sequences, and
these viruses have a high probability of also being identical in the
rest of their genomes [prediction score of 94 of 100; available at
silicianolab.johnshopkins.edu/cps (21)]. The isolation of identical
sequences from multiple wells on different plates across two time
points suggests that these replicating viruses do not accumulate sig-
nificant mutations during 14 d in culture. The lack of immunological
pressure under culture conditions may account for this finding.
There are several nonmutually exclusive explanations for the
prevalence of expanded CD4+ T-cell clones carrying replication-
competent viruses in the latent reservoir. Such cells could be
clonally expanded as part of normal homeostatic processes, in
response to antigen, or as a result of HIV-1 integration into and
disruption or activation of genes that regulate cell division (24, 25).
Alternatively, identical viral sequences could represent a burst of
independent viral integration events into unrelated CD4+ T cells.
Mapping the precise integration sites of the replication-competent
proviruses is required to distinguish definitively between viral
clones produced by CD4+ T-cell clonal expansion and by bursts of
proviral integration.
Clonally expanded CD4+ T cells with shared proviral integration
sites were detected in samples of 1–2 × 106 cells (8, 24, 25), which
are far smaller than the samples assayed in Q2VOA. Only the
largest of these previously described expanded cell clones were
amenable to further characterization, and all 75 proviruses that
were examined molecularly showed gross defects that rendered
them replication-incompetent (8). The finding that large proviral
clones are typically defective is entirely consistent with the obser-
vation that proviral clone size is inversely related to the probability
of reactivation. The larger the archival proviral clone, the less
likely it was to be represented in the replication-competent latent
reservoir. This observation is also in agreement with the finding
that most clonally expanded proviruses integrated into CD4+
T-cell DNA are defective (6–9).
The relative stability of clones in the replication-competent
reservoir has significant implications for assessing efforts aimed at
HIV-1 eradication. In particular, Q2VOA may be a sensitive assay
with which to measure changes in the reservoir that result from
immune-targeted interventions (39–42). Viruses isolated from
the replication-competent latent reservoir demonstrated a broad
range of neutralization sensitivity to bNAbs, and may also show
differing levels of sensitivity to immune-based interventions. The
coexistence of neutralization-sensitive and -resistant clones in the
same patient may be important to consider in development of
clinical strategies using bNAbs in the future. However, whether
the viruses detected in Q2VOA represent species that are pref-
erentially reactivated upon termination of ART in infected indi-
viduals remains to be determined.
In conclusion, we find clones of replication-competent viruses in
the latent reservoir. The viral sequences of these clones show
limited overlap with archived proviral sequences in primary CD4+
T cells, suggesting that the two compartments may be under dif-
ferent types of selective pressure in vivo. Finally, if the reservoir is
maintained by CD4+ T-cell division, it may facilitate immunotherapy-
directed efforts for HIV-1 cure because T-cell activation is thought to
be associated with expression of HIV-1 antigens (39).
Methods
Study Participants. The study was conducted under the approval of The
Rockefeller University Institutional Review Board. Written informed consent
was obtained from all participants under study protocol MNU-0628 at The
Rockefeller University. Eligible participants were adults aged 18–65 y with
HIV-1 infection and undetectable plasma HIV-1 RNA levels (<20 copies per
milliliter) while on ART. Each participant underwent leukapheresis at two
time points 4–6 mo apart.
Q2VOA. Viral outgrowth cultures were performed as previously described (43,
44). Peripheral blood mononuclear cells (PBMCs) from virologically suppressed,
chronically HIV-infected individuals on ART were obtained by leukapheresis.
Briefly, leukapheresis products from each study participant at each time point
were processed, and PBMCs were isolated by density centrifugation on Ficoll
(Thermo Scientific). Cryopreserved PBMCs were then used to isolate total CD4+
T lymphocytes using negative selection by magnetic beads (Miltenyi). Purified
CD4+ T lymphocytes were cultured at 0.3 × 106 cells per well in 24-well plates in
1 mL of RPMI 1640 (Gibco) supplemented with 10% (vol/vol) FBS (HyClone;
Thermo Scientific), 1% penicillin/streptomycin (Gibco), 1 μg/mL phytohemag-
glutinin (Life Technologies), and 100 U/mL IL-2 (Peprotech) at 37 °C and 5%
CO2. Each well also received 1 mL of medium containing 2.5 × 10
6 irradiated
heterologous PBMCs. After 24 h, 1.5 mL of medium was discarded and 106
Table 5. GSI and probability values for HIV env trees under the
null hypothesis that Q2VOA- derived sequences and proviral-
derived sequences are a single mixed group
Q2VOA Proviral
Study ID GSI P value GSI P value
B106 0.184 <0.01 0.114 <0.001
B115 0.61 <0.001 0.43 <0.001
B155 0.421 <0.001 0.125 <0.001
B199 0.15 <0.001 0.071 <0.05
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Fig. 5. Negative correlation between proviral clone size and probability of
reactivation in culture. The frequency of integrated provirus (p) is negatively
correlated with its probability of reactivation in culture (r). Bars denote
interquartile ranges of posterior parameter estimates. The Pearson correla-
tion is computed using median values for large clones. Clones with diverse
frequencies and reactivation probabilities are observed in each patient.
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CD8+-depleted lymphoblasts from an HIV-negative donor were added to each
well as target cells. At day 9, 1 mL of medium was removed and another 106
CD8+-depleted CD4+ T lymphoblasts were added to each well. At day 14, the
supernatant of each well was tested for HIV-1 production using the Lenti-X p24
Rapid Titer Kit (Clontech) according to the manufacturer’s instructions. Under
these conditions, using 0.3 × 106 donor cells, less than 30% of all cultures were
positive for all individuals.
Bulk Cultures. Bulk cultures were performed as previously described (45). Se-
quence analysis on bulk culture was also performed as previously described (28).
Q2VOA Sequence Analysis. The supernatant from p24-positive cultures was
extracted using the Qiagen MinElute Virus Spin kit QIAcube. The cDNA was
produced using 1:10 diluted RNA with SuperScript III reverse transcriptase
(Invitrogen Life Technologies) and the antisense primer env3out 5′–TTG-
CTACTTGTGATTGCTCCATGT–3′ followed by RNase H digestion (Invitrogen
Life Technologies) for 20 min at 37 °C. The full gp160 envwas amplified from
1:40 diluted cDNA using envB5out 5′–TAGAGCCCTGGAAGCATCCAGGAAG–3′
and envB3out 5′–TTGCTACTTGTGATTGCTCCATGT–3′ in the first round and the
second-round nested primers envB5in 5′–TTAGGCATCTCCTATGGCAGGAA-
GAAG–3′ and envB3in 5′–GTCTCGAGATACTGCTCCCACCC–3′.
PCR assays were performed using High Fidelity Platinum Taq (Invitrogen) at
94 °C for 2 min; 94 °C for 15 s, 55 °C for 30 s, and 68 °C for 4 min × 35; and 68 °C
for 15 min. Second-round nested PCR was performed using 1 μL of PCR1
product as a template and High Fidelity Platinum Taq at 94 °C for 2 min; 94 °C
for 15 s, 57 °C for 30 s, and 68 °C for 4 min × 45; and 68 °C for 15 min. PCR2
products were checked using 1% 96-well E-Gels (Invitrogen). PCR bands with
the expected HIV envelope size were quantified and subjected to library
preparation using the Illumina Nextera DNA Sample Preparation Kit (Illumina)
as described (46). Briefly, 10 ng of DNA per band was subjected to
tagmentation, ligated to barcoded sequencing adapters using the Illumina
Nextera Index Kit, and then purified using AmPure Beads XP (Agencourt).
Ninety-six different purified samples were pooled into one library and then
subjected to paired-end sequencing using Illumina MiSeq Nano 300 (Illumina)
cycle kits at a concentration of 15 pM.
Sequence adapters were removed using Cutadapt v1.8.3. Read assembly for
each virus was performed in three steps. First, de novo assemblywas performed
using Spades v3.6.1 to yield long contig files. Contigs longer than 255 bp were
subsequently aligned to an HIV envelope reference sequence, and a consensus
sequence was generated using Geneious 8. Finally, reads were realigned to the
consensus sequence to close gaps, and a final read consensuswas generated for
each sequence. Sequences with double peaks (cutoff consensus identity for any
residue <75%), with stop codons, or shorter than the expected envelope sizes
were omitted from downstream analyses.
Proviral SGA. DNA from 1 to 10 × 106 CD4+ cells from HIV-1–infected indi-
viduals was prepared as previously described (47). Briefly, cells were col-
lected after magnetic isolation and lysed in Proteinase K buffer [100 mM Tris
(pH 8), 0.2% SDS, 200 mM NaCl, 5 mM EDTA] and 20 mg/mL Proteinase K at
56 °C for 12 h. Genomic DNA was extracted by phenol chloroform pre-
cipitation. Aliquots of the resulting DNA were diluted and used as a tem-
plate for full-length gp160 PCRs. All PCRs were performed using High
Fidelity Platinum Taq (Invitrogen). The first PCR was performed at 94 °C for
2 min; 94 °C for 15 s, 58.5 °C for 30 s, and 68 °C for 4 min × 35; and 68 °C for
15 min. Second-round nested PCR was then performed using 1 μL of PCR1
product as a template and High Fidelity Platinum Taq at 94 °C for 2 min;
94 °C for 15 s, 61 °C for 30 s, and 68 °C for 4 min × 45; and 68 °C for 15 min.
PCR2 products were checked using 1% 96-well E-Gels (Invitrogen). Bands
with the expected size of the HIV-1 envelope obtained from diluted DNA
samples that showed an amplification efficiency of less than 30% were
subjected to library preparation and sequencing using the Illumina platform
as described above. Hypermutants, sequences with double peaks (cutoff
consensus identity for any residue <75%), sequences with stop codons, or
sequences shorter than the expected envelope sizes were omitted from
downstream analyses.
Viral Neutralization Testing by TZM.bl. Supernatants from p24-positive
Q2VOA wells were tested against a panel of bNabs using the TZM.bl neu-
tralization assay, as previously described (48, 49). Neutralization assays
were conducted in a laboratory meeting good clinical laboratory practice
quality assurance criteria (laboratory of M.S.S.). Viruses with low median
tissue culture infectious dose (TCID50) titers were only tested against
3BNC117 and 10-1074.
GSI. The GSI (23) was used to calculate the degree of phylogenetic associa-
tion of the env gene sequences. Phylogenies were inferred using PhyML
version 3.0 (50). Multiple bifurcations with intervening zero-length branches
were collapsed to polytomies using the di2multi method implemented in the
ape package for R (51). These phylogram topologies were used to calculate
the gsi values, and P values were determined using 10,000 replicate per-
mutations (23).
Computational Analyses. Bayesian inference was implemented in Stan (52) to
estimate jointly the frequency of integrated proviruses and their reac-
tivation probability. Data from proviral DNA sequencing and viral out-
growth assays were combined across multiple visits, incorporating a prior
probability for the gradual decay of the reservoir (3, 53). We assumed a
weakly informative prior for the frequency of integrated provirus and a
uniform prior for the probability of reactivation. Parameters were estimated
individually for viruses with identical sequences observed at least three times
across both visits (large clones), whereas sequences observed less frequently
were grouped together (small clones). The observed relationship between
clone frequency and reactivation probability also holds in simpler models
incorporating data from single visits only, and when clones that were not
observed in both assays during the same visit are excluded. Additional de-
tails of the inference methods used are provided in SI Methods.
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Fig. 6. Sensitivity of latent viruses to bNAbs. (A) Table shows antibody concentration that inhibits infection by 80% (IC80) titers for selected outgrowth
culture viruses (Fig. 2A) against a panel of bNAbs indicated at the top determined by TZM.bl assay. Viruses with low median tissue culture infectious dose
(TCID50) titers could not be tested against the entire bNAb panel (red, IC80 of 0–0.1 μg/mL; orange, IC80 of 0.1–1.0 μg/mL; yellow, IC80 of 1.0–10 μg/mL; green,
IC80 of 10–50 μg/mL). NT, not tested. (B) Graph shows combined IC80 titers across all four patients for each bNAb. Each dot represents one virus.
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